Provided by Tiger Trade Technology Pte. Ltd.

Oculis

8.74
-0.6000-6.42%
Volume:402.37K
Turnover:3.58M
Market Cap:539.54M
PE:-5.10
High:9.26
Open:9.16
Low:8.70
Close:9.34
52wk High:34.48
52wk Low:8.70
Shares:61.73M
Float Shares:53.44M
Volume Ratio:1.83
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.05
PE(LYR):-3.66

Loading ...

Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company

GlobeNewswire
·
Aug 10

Analysts Are Bullish on These Healthcare Stocks: Oculis Holding (OCS), Xenon (XENE)

TIPRANKS
·
Aug 08

Oculis Holding Q2 EPS $(0.20) Beats $(0.48) Estimate, Sales $392.150K Beat $260.000K Estimate

Benzinga Earnings
·
Aug 07

Oculis Holding AG Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Oculis Q2 2026 Results: Finance Gains Narrow the Net Loss Despite Higher Costs

TradingKey
·
Aug 07

Oculis Q2 Net Loss Narrows Despite Higher Expenses

Reuters
·
Aug 07

Oculis Reports Q2 2026 Financial Results and Provides Company Update

GlobeNewswire
·
Aug 07

Analysts Offer Insights on Healthcare Companies: Oculis Holding (OCS) and Lantheus (LNTH)

TIPRANKS
·
Aug 04

Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Relapses

GlobeNewswire
·
Aug 03

Oculis to Acquire Mitie in £3.1 Billion Deal, Sending Target's Shares Soaring 40%

Deep News
·
Jul 21

Mitie Shares Soar on $4.2 Billion Takeover by OCS

Dow Jones
·
Jul 21

Mitie Halts £100m Share Buyback After Recommended OCS Takeover Offer

TIPRANKS
·
Jul 21

Village Farms Unveils Super Toast Bites, a New Line of Cannabis-Infused Gummies

GlobeNewswire
·
Jul 14

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jul 09

Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference

GlobeNewswire
·
Jul 02

Oculis Advances Privosegtor Into Phase 3 Optic Neuritis Trial: What Investors Should Watch

TIPRANKS
·
Jul 02

Nordic Shares Gain; Oculis Holding Tops Leaders

Dow Jones
·
Jul 01

Oculis Updates Investor Presentation, Emphasizing Late-Stage Neuro-Ophthalmic Pipeline and Cash Runway

TIPRANKS
·
Jun 26

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

GlobeNewswire
·
Jun 16

Oculis to Present Privosegtor at Upcoming Clinical Trials at the Summit 2026

GlobeNewswire
·
Jun 11